Travere Therapeutics
The Vice President of Clinical Development leads Nephrology programs through all clinical phases, serving as the project co-lead for strategy and execution. This senior role involves cross-functional collaboration, regulatory engagement, and medical oversight for rare kidney disease therapies while mentoring staff and maintaining external relationships.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2020
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall
1 day ago
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)
3 days ago
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Travere Therapeutics.
162% above the average for this role
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory
2 weeks ago
Instructor in Glomerular Disease Onco-Nephrology - Renal-Electrolyte and Hypertension Division
University of Pennsylvania
Nephrologist
University of Wisconsin–Madison
Organ Health Specialist
Natera
Assistant Professor
University of Pennsylvania
General Nephrologist
UofL Health
Vice President, Clinical Development
Aurabiosciences